ACH vs card for research peptides

By Daniel Marsh, Payments Editor

Query focus: ACH vs card research peptides

Switching from cards to ACH (or crypto) changes the payment rail. It does not erase product legality questions, platform policy, or high-risk classification. Residual compliance and underwriting risk remain with the business model.

RetryHub helps with merchant-account placement and underwriting prep; PayFresco is a separate payments + CRM / orchestration product.

What changes — and what does not

May change: network monitoring programs, chargeback mechanics, settlement timing, bank partner appetite for ACH vs card.
Does not change: whether the catalog is lawful for how you market and ship it; whether RUO language matches intended use; whether compounding or prescription models need separate pharmacy frameworks.

RUO ≠ FDA clearance

Research-use-only labeling is not the same as FDA clearance or approval for human use. FDA warning letters commonly analyze intended use (marketing, claims, and how a product is positioned) over disclaimer text alone. Operators should read current FDA warning letters on fda.gov for intended-use findings rather than relying on second-hand quotes. This page does not invent letter text.

Keep RUO ecommerce separate from compounding paths

RUO ecommerce, 503A/503B compounding, and GLP-1 shortage compounding are separate models. Do not blend them when comparing ACH vs card. Each has different licensing, marketing, and underwriting expectations.

Practical underwriting framing

If you process cards, ACH, or both, document product claims, policies, fulfillment, and prior processor outcomes honestly. ACH or crypto alone is not a remediation plan for a declined or restricted card account. RetryHub industry context: peptides and research chemicals.

Is this a fit?

Who it’s for: High-risk eCommerce and subscription businesses in the US, EU/UK, and Canada that need a dedicated merchant account, including merchants declined, limited, or shut down by Stripe, PayPal, Shopify Payments, or Square. Industries listed on retryhub.com include supplements, CBD and hemp, research-use peptides, vape, tobacco, firearms and accessories, adult, subscriptions, coaching, digital products and SaaS, travel and ticketing, and high-ticket eCommerce.
Who it isn’t for: Businesses selling illegal products, anyone looking for MID rental, load balancing, or ways to hide a prior termination, and merchants who need an approval guarantee.
Pricing: Free to apply, with no setup fees and no credit check to apply. Processing pricing is quoted after underwriting review; the acquiring bank sets rates and any reserve.
Integrations: After approval you receive MID and integration details, and the team helps you connect your checkout. Gateway and cart compatibility is confirmed during setup for your stack.
Limits: RetryHub is a placement and onboarding partner, not the bank. Approval is subject to underwriting and not guaranteed. Coverage is the US, EU/UK, and Canada through region-specific applications; the US application collects owner SSN details. RetryHub may receive compensation from providers it works with, as disclosed on retryhub.com.

Apply: retryhub.com/apply